![Legend Biotech Corporation](/common/images/company/N_LEGN.png)
Legend Biotech Corporation (LEGN)
NASDAQ
Quarter End | 6 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
総売上 | 23.04M | 44.54M | 73.33M | 96.01M | 137.59M | 93.99M | 186.52M | 160.21M |
営業利益 | -108.42M | -116.13M | -104.32M | -92.75M | -62.93M | -117.86M | -41.97M | -71.49M |
税引前収入 | -184.11M | -111.97M | -198.84M | -62.5M | -146.81M | -59.79M | -17.97M | -120.89M |
純利益 | -184.43M | -112.1M | -199.13M | -62.21M | -144.82M | -59.79M | -18.2M | -125.32M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -118.04M | -126.86M | -98.47M | -92.49M | -91.41M | -54.31M | -104.65M | -23.76M |
EBITDA | -108.42M | -116.13M | -94.39M | -87.58M | -78.03M | -117.86M | -30.88M | -82.58M |
年末 2023年12月31日 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 49.13M | 57.26M | 75.68M | 89.79M | 117.01M | 285.14M |
営業利益 | -15.43M | -137.05M | -229.2M | -373.04M | -458.05M | -442.22M |
税引前収入 | -1.62M | -130.37M | -307.62M | -386.21M | -445.72M | -520.12M |
純利益 | -2.78M | -132.97M | -303.48M | -386.21M | -446.35M | -518.25M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.014 | -0.665 | -1.141 | -1.252 | -1.352 | -1.424 |
EBIT | -14.99M | -134.98M | -306.41M | -380.08M | -464.01M | -467.06M |
EBITDA | -13.75M | -131.79M | -219.27M | -359.12M | -439.66M | -421.77M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約